Hospital Clinico Universitario de Valencia -ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2022

  1. Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial

    Thrombosis and haemostasis, Vol. 122, Núm. 10, pp. 1653-1661

2021

  1. Rationale, design and methodology of TESEO study: a registry of thrombosis and neoplasia of SEOM (Spanish Society of Medical Oncology)

    Clinical and Translational Oncology, Vol. 23, Núm. 4, pp. 799-811

2020

  1. A snapshot of cancer-associated thromboembolic disease in 2018–2019: First data from the TESEO prospective registry

    European Journal of Internal Medicine, Vol. 78, pp. 41-49

  2. TESEO, cancer-associated thrombosis registry from the Spanish Society of Medical Oncology (SEOM)

    Clinical and Translational Oncology

2015

  1. Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancer

    PLoS ONE, Vol. 10, Núm. 1

2014

  1. First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study

    British Journal of Cancer, Vol. 111, Núm. 2, pp. 241-248